Brilliant Earth officer proposes $12.3K share sale

Accepted by SEC EDGAR 05/18/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Brilliant Earth Group, Inc. (BRLT) officer Sharon Dziesietnik filed notice of a proposed sale of 10,124 common shares, with an aggregate market value of $12,250.04 and an approximate sale date of May 18, 2026. The notice states that she acquired 10,124 shares from the issuer through a stock award on May 15, 2026, and lists August 14, 2025 in the field for the date of plan adoption or giving of instruction if relying on Rule 10b5-1. It also reports 19,687 common shares sold on February 18, 2026, for gross proceeds of $26,990.88.

Key Figures

Proposed sale: 10,124 common shares Aggregate market value: $12,250.04 Shares outstanding: 16,258,882 common shares +3 more

6 metrics

Proposed sale 10,124 common shares Approximate sale date: May 18, 2026

Aggregate market value $12,250.04 Value associated with the proposed sale

Shares outstanding 16,258,882 common shares Share count reported in the notice

Shares acquired 10,124 shares Acquired through a stock award on May 15, 2026

Prior shares sold 19,687 common shares Sold on February 18, 2026

Gross proceeds $26,990.88 Proceeds from the February 18, 2026 sale

Key Terms

Rule 10b5-1, Stock Award, attorney-in-fact

3 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Stock Award financial

"Nature of Acquisition Transaction: Stock Award"

attorney-in-fact regulatory

"as attorney-in-fact for Sharon Dziesietnik"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares is the BRLT officer reporting for sale?

Sharon Dziesietnik reported a proposed sale of 10,124 common shares, with an aggregate market value of $12,250.04 and an approximate sale date of May 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002035090
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Brilliant Earth Group, Inc.
SEC File Number	001-40836
Address of Issuer	300 GRANT AVENUE 3RD FLOOR SAN FRANCISCO CALIFORNIA 94108
Phone	(415) 918-5551
Name of Person for Whose Account the Securities are To Be Sold	Dziesietnik Sharon
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	10124	12250.04	16258882	05/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2026	Stock Award	Issuer			10124	05/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sharon Dziesietnik 300 GRANT AVENUE 3RD FLOOR SAN FRANCISCO CA 94108	Common	02/18/2026	19687	26990.88

144: Remarks and Signature

Remarks
Date of Notice	05/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Sharon Dziesietnik
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)